Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion type Assertion NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_head.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion description "[The interleukin-3 receptor ? chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion evidence source_evidence_literature NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion SIO_000772 24030378 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion wasDerivedFrom befree-20150227 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion wasGeneratedBy ECO_0000203 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.